Declared Security Transactions 2015-2016

Declared Security Transactions 2015-2016

Date Name and Function Transaction Type, Number & Security Date, Place, Price & Transaction Volume
June 9, 2016 Jens Holstein, CFO Sale of 9,997 MorphoSys AG shares; the shares sold derive from the Long-Term-Incentive (LTI-) Program 2012 of MorphoSys; from overall 12,997 shares out of this program, Mr. Holstein holds 3,000 shares. June 7, 2016
XETRA, EUR 47.017
EUR 470,028.949
May 17, 2016 Dr. Marlies Sproll, CSO Sale of 3,100 MorphoSys AG shares; the shares sold derive from the Long-Term-Incentive (LTI-) Program 2012 of MorphoSys; from overall 12,997 shares out of this program, Dr. Sproll holds 6,760 shares. May 13, 2016
XETRA, EUR 45.1284
EUR 139,898.04
May 17, 2016 Dr. Marlies Sproll, CSO Sale of 3,137 MorphoSys AG shares; the shares sold derive from the Long-Term-Incentive (LTI-) Program 2012 of MorphoSys; from overall 12,997 shares out of this program, Dr. Sproll holds 6,760 shares. May 12, 2016
XETRA, EUR 43.8891
EUR 137,680.11
December 17, 2015 Dr. Simon Moroney, CEO Purchase: 18,800 convertible bonds were converted into MorphoSys AG shares. Dr. Moroney is holding the shares received. December 16, 2015
off-exchange, EUR 16.79
EUR 315,252.00
December 17, 2015 Dr. Marlies Sproll, CSO Sale: 9,500 convertible bonds were converted into MorphoSys AG shares and subsequently sold. December 16, 2015
XETRA, EUR 56.1934
EUR 533,837.30
December 17, 2015 Dr. Marlies Sproll, CSO Purchase: 14,000 convertible bonds were converted into MorphoSys AG shares. Dr. Sproll is holding the shares received. December 15, 2015
off-exchange, EUR 16.79
EUR 235,060.00
December 17, 2015 Dr. Marlies Sproll, CSO Sale: 9,500 convertible bonds were converted into MorphoSys AG shares and subsequently sold. December 15, 2015
XETRA, EUR 56.0253
EUR 532,240.35
June 8, 2015 Dr. Marlies Sproll, CSO Sale of 2,667 MorphoSys AG shares; the shares were granted within MorphoSys's long term incentive (LTI) program 2011 after a four-year waiting period. The shares were subsequently sold. June 4, 2015
XETRA, EUR 65.6343
EUR 175,046.68
June 8, 2015 Dr. Marlies Sproll, CSO Sale of 2,667 MorphoSys AG shares; the shares were granted within MorphoSys's long term incentive (LTI) program 2011 after a four-year waiting period. The shares were subsequently sold. June 3, 2015
XETRA, EUR 65.8605
EUR 175,649.95
June 8, 2015 Dr. Marlies Sproll, CSO Sale of 2,666 MorphoSys AG shares; the shares were granted within MorphoSys's long term incentive (LTI) program 2011 after a four-year waiting period. The shares were subsequently sold. June 2, 2015
XETRA, EUR 65.6746
EUR 175,088.48
June 8, 2015 Jens Holstein, CFO Sale of 3,381 MorphoSys AG shares; the shares were granted within MorphoSys's long term incentive (LTI) program 2011 after a four-year waiting period. The shares were subsequently sold. June 4, 2015
XETRA, EUR 65.6343
EUR 221,909.57
June 8, 2015 Jens Holstein, CFO Sale of 5,381 MorphoSys AG shares; the shares were granted within MorphoSys's long term incentive (LTI) program 2011 after a four-year waiting period. The shares were subsequently sold. June 3, 2015
XETRA, EUR 65.8605
EUR 354,395.35
June 8, 2015 Jens Holstein, CFO Sale of 5,370 MorphoSys AG shares; the shares were granted within MorphoSys's long term incentive (LTI) program 2011 after a four-year waiting period. The shares were subsequently sold. June 2, 2015
XETRA, EUR 65.6746
EUR 352,672.60
May 13, 2015 Dr. Frank Morich, Deputy Chairman of the Supervisory Board Purchase of 1,000 MorphoSys AG shares May 12, 2015
Frankfurt, EUR 63.51
EUR 63,510.00
Apr 2, 2015 Dr. Gerald Möller,
Chairman of the Supervisory Board
Purchase of 2,000 MorphoSys AG shares March 27, 2015
Frankfurt, EUR 56.70
EUR 113,400.00
Apr 2, 2015 Karin Eastham, Member of the Supervisory Board Purchase of 1,000 MorphoSys AG shares March 27, 2015
OTC, USD 61.8129
USD 61,812.90